Simplex Trading’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,540
| Closed | -$18.5K | – | 8824 |
|
|
2024
Q4 | $20K | Buy |
+1,540
| New | +$14.3K | ﹤0.01% | 6683 |
|
|
2024
Q3 | – | Sell |
-3,090
| Closed | -$46.6K | – | 8815 |
|
|
2024
Q2 | $68K | Sell |
3,090
-4,217
| -58% | -$130K | ﹤0.01% | 5763 |
|
|
2024
Q1 | $429K | Buy |
7,307
+6,324
| +643% | +$272K | ﹤0.01% | 3996 |
|
|
2023
Q4 | $21K | Buy |
983
+690
| +235% | +$10.4K | ﹤0.01% | 6879 |
|
|
2023
Q3 | $6K | Buy |
+293
| New | +$11.5K | ﹤0.01% | 7522 |
|
|
2023
Q2 | – | Sell |
-1,304
| Closed | -$539K | – | 9261 |
|
|
2023
Q1 | $608K | Buy |
1,304
+1,282
| +5,827% | +$678K | ﹤0.01% | 3075 |
|
|
2022
Q4 | $8K | Sell |
22
-339
| -94% | -$130K | ﹤0.01% | 7718 |
|
|
2022
Q3 | $117K | Buy |
361
+195
| +117% | +$62.8K | ﹤0.01% | 5296 |
|
|
2022
Q2 | $43K | Buy |
166
+75
| +82% | +$19.2K | ﹤0.01% | 6695 |
|
|
2022
Q1 | $27K | Sell |
91
-1,235
| -93% | -$431K | ﹤0.01% | 7889 |
|
|
2021
Q4 | $467K | Sell |
1,326
-2,255
| -63% | -$702K | ﹤0.01% | 3904 |
|
|
2021
Q3 | $2.37M | Sell |
3,581
-149
| -4% | -$52.8K | ﹤0.01% | 1945 |
|
|
2021
Q2 | $2.48M | Buy |
+3,730
| New | +$2.15M | ﹤0.01% | 1891 |
|
|
2021
Q1 | – | Sell |
-220
| Closed | -$234K | – | 9158 |
|
|
2020
Q4 | $203K | Buy |
220
+208
| +1,733% | +$219K | ﹤0.01% | 4579 |
|
|
2020
Q3 | $12K | Sell |
12
-422
| -97% | -$454K | ﹤0.01% | 6697 |
|
|
2020
Q2 | $439K | Sell |
434
-924
| -68% | -$858K | ﹤0.01% | 3068 |
|
|
2020
Q1 | $1.18M | Sell |
1,358
-759
| -36% | -$754K | ﹤0.01% | 1732 |
|
|
2019
Q4 | $2.27M | Buy |
2,117
+1,821
| +615% | +$1.86M | 0.01% | 1374 |
|
|
2019
Q3 | $273K | Sell |
296
-471
| -61% | -$517K | ﹤0.01% | 3258 |
|
|
2019
Q2 | $866K | Buy |
+767
| New | +$840K | ﹤0.01% | 2038 |
|
|
2018
Q4 | – | Sell |
-483
| Closed | -$543K | – | 7235 |
|
|
2018
Q3 | $733K | Sell |
483
-355
| -42% | -$547K | ﹤0.01% | 2201 |
|
|
2018
Q2 | $1.31M | Sell |
838
-227
| -21% | -$296K | 0.01% | 1547 |
|
|
2018
Q1 | $1.23M | Buy |
1,065
+579
| +119% | +$762K | 0.05% | 318 |
|
|
2017
Q4 | $575K | Sell |
486
-1,317
| -73% | -$1.65M | 0.02% | 643 |
|
|
2017
Q3 | $2.42M | Buy |
1,803
+654
| +57% | +$689K | 0.1% | 155 |
|
|
2017
Q2 | $928K | Buy |
1,149
+157
| +16% | +$109K | 0.04% | 391 |
|
|
2017
Q1 | $611K | Buy |
992
+24
| +2% | +$14.6K | 0.03% | 577 |
|
|
2016
Q4 | $518K | Buy |
968
+885
| +1,066% | +$442K | 0.03% | 529 |
|
|
2016
Q3 | $43K | Sell |
83
-194
| -70% | -$91.4K | ﹤0.01% | 2225 |
|
|
2016
Q2 | $113K | Buy |
+277
| New | +$127K | 0.01% | 1394 |
|
Other funds holding KYNB
AC
CCM
Simplex Trading's KYNB Position: Q1 2025 in Review
Simplex Trading sold out of Kyntra Bio (KYNB) in Q1 2025, closing a stake of 1,540 shares — an estimated $18.5K sold.
Simplex Trading first reported a position in KYNB in Q2 2016 and held it in 30 quarters. The position peaked at $2.48M in Q2 2021. 54 funds tracked by Wall St. Rank hold KYNB as of Q1 2025.
- Simplex Trading reported no remaining Kyntra Bio position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 1,540 Kyntra Bio shares in Q1 2025, an estimated $18.5K.
- Simplex Trading first reported a position in Kyntra Bio in Q2 2016 and held it in 30 quarters.
- Simplex Trading's Kyntra Bio position peaked at $2.48M in Q2 2021.
- 54 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.